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Abstract
Background: A high rectal and oropharyngeal sexually transmitted infection (STI) burden has been reported
among men who have sex with men (MSM) in many regions, but little data exists on rectal and oropharyngeal STIs
among MSM in China. The purpose of this study was to determine the prevalence of gonorrhea and chlamydia at
different anatomic sites among MSM in Guangzhou, China.
Methods: We recruited a cross-sectional sample of MSM in one Chinese city and collected detailed information
about socio-demographic characteristics and sexual behaviors. Men had urine, rectal, and pharyngeal swab samples
tested for gonorrhea and chlamydia using nucleic acid amplification tests (NAAT). Univariate and multivariate
logistic regressions were used to evaluate factors associated with gonorrhea and chlamydia. Among men without
any STI symptoms, we also examined the prevalence of gonorrhea and chlamydia by anatomical site.
Results: We enrolled 463 men between January 2015 and March 2017. A total of 58/463 (12.5%) of men had
gonorrhea and 84/463 (18.1%) had chlamydia. MSM with gonorrhea were more likely to have been recruited from
the STI clinic (OR 3.41, 95% CI 1.94–5.99), living with HIV (OR 2.41, 95% CI 1.18–4.92), diagnosed had STI co-infection
(OR 2.55, 95% CI 1.39–4.69). MSM with chlamydia were more likely to be students (OR 1.8, 95% CI 0.99–3.39). Most
gonorrhea (34/58, 59%) and chlamydia (64/84, 76%) infections were not associated with STI symptoms.
Conclusion: Asymptomatic gonorrhea and chlamydia infection were common in this sample of Chinese MSM.
Further research is necessary to determine optimal STI screening programs.
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Background
Gonorrhea and chlamydia infections are the most common
curable sexually transmitted infections (STIs). In 2012 there
were an estimated 78 million (53–110 million) new gonor-
rhea infections and 131 million (100–166 million) chla-
mydia infections respectively, in 2012 [1]. Men who have
sex with men (MSM) have particularly high rates of gonor-
rhea and chlamydia [2–7].
Extragenital gonorrhea and chlamydia are major public
health problems among MSM. Compared with genital
infections, rectal and pharyngeal gonorrhea and chla-
mydia infections are more likely to be asymptomatic [5]
and can easily be missed without screening. Several
high-income countries recommend regular screening of
extragenital sites (rectum and pharynx) among sexually
active MSM [8–10]. World Health Organization MSM
preventive guidelines also support gonorrhea and chla-
mydia screening among MSM with a higher burden of
asymptomatic disease [11]. This suggests the need for
research to understand the burden of extragenital gonor-
rhea and chlamydia among MSM in different settings.
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Despite high HIV prevalence and frequent condomless
sex among MSM in China, [12–18] there are limited
data on MSM extragenital gonorrhea and chlamydia.
[19, 20] Better understanding the burden of rectal and
pharyngeal gonorrhea and chlamydia can provide useful
information for research and screening pilots. We
undertook this study in Guangzhou, China. Guangzhou
is a provincial capital city in south China with a concen-
trated HIV infection in MSM [21] and a strong STI net-
work. The purpose of this study was to determine the
prevalence of gonorrhea and chlamydia at different ana-
tomic sites among MSM in Guangzhou, China.
Methods
Study population and procedure
We recruited a cross-sectional convenience sample of
MSM between January 2015 and March 2017. Enrollment
criteria included being male, currently living in Guangzhou,
being at least 18 years of age, self-identifying as gay or bi-
sexual, and receiving no antibiotics in the past month.
We recruited patients from two clinics at the Derma-
tology Hospital of Southern Medical University, a ter-
tiary care center with experience serving MSM. The first
was an STI clinic run by the hospital, through which any
patient who had STI complaints or concerns could re-
quest to see a doctor. Patients meeting enrollment cri-
teria who agreed to participate were asked to join the
research study. The second was a weekend community
clinic sponsored by the Zhitong Guangzhou LGBT (les-
bian, gay, bisexual, and transgender) Center, an MSM
community organization. This community clinic pro-
vides free HIV and syphilis testing services for MSM.
During this study, Zhitong also advertised our project
on their website and social media account.
Data collection
At enrollment, we collected baseline socio-demographic
information, sexual behavior, and STI history. Informa-
tion about symptoms was collected as a single item. If
men had symptoms consistent with an STI, this was
noted. There was no effort to attribute symptoms to a
particular pathogen in cases of co-infection. All partici-
pants underwent physical examination, and any abnor-
mal findings (i.e. warts) were recorded. Urine, rectal and
pharyngeal swab samples were collected for gonorrhea
and chlamydia testing. Venous blood samples were col-
lected for HIV and syphilis testing. Men with positive
tests were treated according to Chinese STI clinical
management guidelines.
Laboratory methods
Oropharyngeal, rectal, and urine specimens were tested
for gonorrhea and chlamydia using the Cobas 4800 sys-
tem (Roche Moleculer Systems, Inc. New Jersey, USA).
Blood samples were tested for syphilis using a toluidine
red unheated serum test (TRUST, Rongsheng
Bio-technology Limited Corporation, Shanghai, China)
and Treponema pallidum particle agglutination test
(TPPA, Fujirebio Inc., Japan). Blood samples were tested
for HIV using two antibody tests - a rapid HIV antibody
test (Wantai, Beijing, China) and a second antibody test
(Abon Biopharm, Hangzhou, China). If both were posi-
tive, another blood sample was collected for Western
blot confirmation (MP Biomedical, Singapore).
Men were considered infected with gonorrhea and
chlamydia if respective tests were positive. Men with
positive TRUST and TPPA tests were considered to have
syphilis infection, unless a documented history of previ-
ously treated syphilis was available. Men with positive
HIV screening and confirmatory tests were considered
to have HIV infection. Anogenital warts and anogenital
herpes were diagnosed according to the diagnostic
criteria for China’s notifiable diseases reporting system
(Version 2008). These diagnoses are mainly based on ex-
posure history and consistent clinical findings.
Data analysis
We described socio-demographic characteristics, sexual
risk behaviors, and STI (by anatomic site) among men.
We compared men presenting to the STI clinic and men
presenting to the MSM community clinic. Chi-square
tests were used to compare gonorrhea/chlamydia preva-
lence between the STI clinic and MSM community
groups. Univariate and multivariate logistic regressions
were used to evaluate factors associated gonorrhea and
chlamydia, respectively. We also calculated the fre-
quency of men with gonorrhea and chlamydia who were
asymptomatic. All data were analyzed using SAS 9.2
(SAS, Cary, USA).
Ethics, consent and permissions
Ethical approval for this study was obtained from the
Science Research Ethical Committee of the Dermatology
Hospital of Southern Medical University (GDDHLS-
201502). Written informed consent was waived because the
risk associated with participating in this study was deemed
minimal and involved no procedures requiring consent out-
side of the context of participating in the study. This was
approved by the Chinese IRB. It is also in accordance with
DHHS (45 CFR 46.117). Verbal consent was obtained be-
fore participants were enrolled.
Results
We recruited 463 MSM to join the study. One-hundred
and fifty-three men were from the STI clinic and 310
men were from the MSM community clinic. Most men
were young, Han ethnicity, unmarried, non-students,
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and had a higher education level. Socio-demographic
characteristics are shown in Table 1.
Among 463 men, a total of 58 (12.5%) men had gonor-
rhea infection. The gonorrhea prevalence at urethral, rec-
tal, and pharyngeal sites was 5.2% (24/463), 6.1% (28/463),
and 3.9% (18/463), respectively (Table 2). Among all men
with gonorrhea, most men (34/58, 59%) did not have STI
symptoms. MSM with asymptomatic extragenital gonor-
rhea were common (Fig. 1). MSM with gonorrhea were
more likely to have been recruited from the STI clinic
(OR 3.41, 95% CI 1.94–5.99), living with HIV (OR 2.41,
95% CI 1.18–4.92), and diagnosed with STI co-infection
(OR 2.55, 95% CI 1.39–4.69) (Table 3).
A total of 84 men (18.1%) had chlamydia infection at any
site. The chlamydia prevalence at the urethral, rectal and
oropharyngeal sites was 6.7% (31/463), 11.2% (52/463), and
1.3% (6/463), respectively. Among all men with chlamydia,
most men (64/84, 76%) did not have STI symptoms. 61.3%
of urethral infections, 83.3% of rectal infections and 83.3%
of pharyngeal infections were asymptomatic (Fig. 1). There
was a trend towards MSM with chlamydia being more
likely to be students (OR 1.8, 95% CI 0.99–3.39).
The chlamydia and gonorrhea coinfection rate was
5.6% (n = 26). Sixty men (13.0%) were living with HIV
infection. Eighty-four men (18.1%) had other STIs, in-
cluding syphilis, anogenital wards, or herpes.
Discussion
Our study evaluated the prevalence of urethral, anal, and
pharyngeal gonorrhea and chlamydia among MSM in
Guangzhou, China. This study expands the limited lit-
erature on MSM extragenital gonorrhea and chlamydia
Table 1 Demographic and behavioral characteristics of participants from the hospital STI clinic and the community-based MSM
clinic (n = 463), 2015–2017
STI Clinic
n (frequency)
Community clinic
n (frequency)
P-value
Age(years) 0.159
< 25 50/153 (32.7%) 128/310 (41.3%)
25~35 68/153 (44.4%) 113/310 (36.4%)
> 35 35/153 (22.9%) 69/310 (22.3%)
Ethnicity 0.088
Han 146/153 (95.4%) 282/310 (91.0%)
Others 7/153 (4.6%) 28/310 (9.0%)
Marital status < 0.0001
Unmarried 101/153 (66.0%) 265/310 (86.6%)
Married 50/153 (32.7%) 35/310 (11.4%)
Other 2/153 (1.3%) 6/310 (2.0%)
Student 0.049
Yes 14/153 (9.2%) 49/310 (15.8%)
No 139/153 (90.8%) 261/310 (84.2%)
Local residence time 0.854
0–6 months 22/153 (14.4%) 44/310 (14.5%)
6–12months 9/153 (5.9%) 22/310 (7.3%)
Over 1 year 122/153 (79.7%) 237/310 (78.2%)
Education level 0.065
Junior middle school and below 22/153 (14.4%) 24/310 (7.8%)
Senior middle school 22/153 (14.4%) 41/310 (13.2%)
Senior middle school above 109/153 (71.2%) 245 (79.0%)
Any STI related symptoms < 0.001
Yes 49/153 (32.0%) 31/310 (10.0%)
No 104/153 (68.0%) 279/310 (90.0%)
Condom use in the last 6 months < 0.001
Any condom less sex 141/153 (92.8) 305/310 (99.3%)
Consistent condom use 11/153 (7.2%) 2/310 (0.7%)
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prevalence in an low and middle income country con-
text. This study also compares two different populations
of MSM within the same city, providing insight about
risk in these groups.
The overall chlamydia prevalence was 18.1%, and the
gonorrhea prevalence was 12.5%. The burden of chla-
mydia and gonorrhea are similar to findings from other
Chinese studies in Shenzhen [19] and Kunming [20].
Over half of all STIs were asymptomatic, consistent with
other studies. Given that World Health Organization
Guidelines recommend MSM screening for asymptom-
atic urethral and rectal gonorrhea/chlamydia if preva-
lence is greater than 1–2% [11], our data suggest that
screening would be indicated in this population.
We found that the majority of MSM STI infections
were asymptomatic. This is consistent with a previous
study from the United States [5]. This trend is more pro-
nounced for rectal and pharyngeal infections [22]. The
high burden of extra-genital STIs among MSM may help
researchers and policy makers making decisions about
routine screening guidelines.
Our data suggest that more MSM with symptoms seek
care at the STI clinic compared to the MSM community
clinic. This is consistent with the STI literature on MSM
seeking care at STI clinics compared to community clinics
[5]. Asymptomatic infections were especially common in
the MSM community clinic. This suggests that asymp-
tomatic screening programs may be more appropriate for
MSM community clinics and related settings.
Our study has implications for STI research priorities
among MSM. Better understanding the burden of asymp-
tomatic extragenital STIs may be helpful in designing pro-
spective screening studies or modelling research. Despite
the fact that many guidelines recommend periodic STI
screening among MSM, there are also barriers to screening
(cost. Feasibility, logistics). The US Preventive Service Task
Force found insufficient evidence to recommend gonorrhea
and chlamydia testing among men when it last reviewed
Table 2 Gonorrhea and chlamydia infection by anatomic sites among 463 MSM in an STI clinic and a community-based clinic in
Guangzhou China, 2015–2017
Variables STI clinic
n (frequency)
Community clinic
n (frequency)
Total
n (frequency)
P*
Gonorrhea 34/153(22.2%) 24/310 (7.7%) 58/463 (12.5%) < 0.001
Urethral 22/153 (14.4%) 2/310 (0.7%) 24/463 (5.2%) < 0.001
Rectal 11/153 (7.2%) 17/310 (5.5%) 28/463 (6.1%) 0.469
Pharyngeal 6/153 (3.9%) 12/310 (3.9%) 18/463 (3.9%) 0.979
Chlamydia 29/153 (19.0%) 55/310(17.7%) 84/463 (18.1%) 0.750
Urethral 18/153 (11.8%) 13/310 (4.2%) 31/463 (6.7%) 0.002
Rectal 10/153 (6.5%) 42/310 (13.6%) 52/463 (11.2%) 0.025
Pharyngeal 1/153 (0.7%) 5/310 (1.6%) 6/463 (1.3%) 0.391
HIV 20/153 (13.1%) 40/310 (12.9%) 60/463 (13.0%) 0.959
aOther STIs 49/153 (32.0%) 35/310 (11.3%) 84/463 (18.1%) < 0.001
*Chi-squared test
aOther STIs refers to syphilis, ano-genital warts and herpes
26 participants were co-infected with gonorrhea and chlamydia
Fig. 1 Proportion of symptomatic and asymptomatic urethral, rectal and pharyngeal chlamydia and gonococcal infections
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the evidence [23]. Accurate assessment of asymptomatic
extragenital MSM STIs will also be helpful for the develop-
ment of local policies and practice guidelines.
Our study has several limitations. First, our study was
limited to two clinics taking place in the same hospital
in Guangzhou. This study is not representative of MSM
in China and caution should be used in making general-
izations to other settings. Second, the study was
cross-sectional in nature, so we cannot draw conclusions
regarding causality. Third, although we asked patients
about their symptoms, the main purpose of the survey
instrument was not to better understand co-existing
Table 3 Factors associated with gonorrhea and chlamydia infections among 463 MSM in Guangzhou China, 2015–2017
gonorrhea(%) OR (95%CI) P AOR chlamydia(%) OR(95%CI) P AOR
Age(years)
< 25 26/178 (14.6%) 1.81 (0.81,4.02) 0.148 – 37/178 (20.8%) 1.34 (0.71,2.53) 0.362
25~35 23/181 (12.7%) 1.54 (0.68,3.46) 0.299 – 30/181 (16.6%) 1.02 (0.53,1.95) 0.960
> 35 9/104 (8.7%) 1.00 – 17/104 (16.4%) 1.00
Ethnicity
Han 52/428 (12.2%) 0.67(0.27,1.69) 0.394 – 76/428 (17.8%) 0.73(0.32,1.67) 0.453
Others 6/35 (17.1%) 1.00 – 8/35 (22.9%) 1.00
Marital status
Unmarried 45/366 (12.3%) 0.98(0.12,8.16) 0.986 – 63/366 (17.2%) 0.62(0.12,3.16) 0.568
Married 12/85 (14.1%) 1.15(0.13,10.20) 0.899 – 17/85 (20.0%) 0.75(0.14,4.05) 0.737
Other 1/8 (12.5%) 1.00 – 2/8 (25.0%) 1.00
Student
Yes 11/63 (17.5%) 1.59(0.78,3.26) 0.206 – 17/63 (27.0%) 1.84(0.99,3.39) 0.053
No 47/400 (11.8%) 1.00 – 67/400 (16.8%) 1.00
Local residence time
0–6 months 12/66 (18.2%) 1.59(0.79,3.21) 0.194 – 12/66 (18.2%) 0.99(0.50,1.95) 0.969
6–12 months 2/31(6.5%%) 0.49(0.11,2.14) 0.346 – 4/31 (12.9%) 0.66(0.22,1.94) 0.449
Over 1 year 44/359 (12.3%) 1.00 – 66/359 (18.4%) 1.00
Education level
Junior middle school and below 6/46 (13.0%) 1.03(0.41,2.57) 0.949 – 7/46 (15.2%) 0.74(0.32,1.73) 0.488
Senior middle school 7/63 (11.1%) 0.86(0.39,2.00) 0.723 8/63 (12.7%) 0.60(0.27,1.32) 0.204
Senior middle school above 45/354 (12.7%) 1.00 69/354 (19.5%) 1.00
Recruited from
STI clinic 34/153 (22.2%) 3.41(1.94,5.99) < 0.01 2.71(1.49,4.96) 29/153 (19.0%) 1.08(0.66,1.79) 0.750 –
Community clinic 24/310 (7.7%) 1.00 1.00 55/310 (17.7%) 1.00 –
Any STI related symptoms
Yes 24/80 (30.0%) 4.40(2.43,7.97) < 0.01 2.89(1.53,5.47) 20/80 (25.0%) 1.66(0.94,2.95) 0.082 –
No 34/383 (8.9%) 1.00 1.00 64/383 (16.7%) 1.00 –
Condom use in the last 6 months
Any condom less sex 56/446 (12.6%) 0.79(0.17,3.66) 0.763 – 82/446 (18.4%) 1.23(0.27,5.70) –
Consistent condom use 2/13 (15.4%) 1.00 – 2/13 (15.4%) 1.00 –
No. of sex partners in last 6 months – 1.04(0.94,1.15) 0.424 – – 1.09(1.01,1,18) 0.0495 1.09(1.01,1,18)
HIV positive
Yes 15/60 (25.0%) 2.79(1.44,5.42) 0.0025 2.41(1.18,4.92) 15/60 (25.0%) 1.61(0.85,3.06) 0.1424 –
No 43/403 (10.7%) 1.00 1.00 69/403 (17.1%) 1.00 –
Other STIs#
Yes 19/84 (22.6%) 2.55(1.39,4.69) 0.0026 – 18/84 (21.4%) 1.29(0.72,2.32) 0.3885 –
No 39/379 (10.3%) 1.00 – 66/379 (17.4%) 1.00 –
#: other STIs refers to syphilis, ano-genital warts and ano-genital herpes
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symptoms. In addition, symptoms may not have been re-
lated to an STI. Pharyngeal symptoms have a wide dif-
ferential diagnosis, so our estimate of asymptomatic
cases of pharyngeal chlamydia and gonorrhea are likely
underestimates.
Conclusions
Our findings show that chlamydia and gonorrhea preva-
lence are high among Chinese MSM. Enhanced screen-
ing and treatment of rectal chlamydia and gonorrhea
among MSM is necessary to improve sexual health.
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